Changing attitudes towards narcotic use in cancer pain management in Japan.
Morphine consumption for medical purposes in Japan showed a 17-fold increase between 1979 and 1989, due to increased use in cancer pain management. This increase is a reflection of the improving attitude of the health care professionals and health policy makers towards narcotics use. The WHO Cancer Pain Relief Programme has ultimately become the basis for a national cancer pain relief programme. The Ministry of Health and Welfare amended the Narcotics and Psychotropics Control Law in 1990, to improve accessibility of morphine preparations to cancer patients with pain, and edited four manuals for palliative care, that include guidelines on cancer pain relief, and legislative management of narcotics use in hospital, clinic and pharmacy.
Takeda
F
F
Neurosurgery Clinic, Saitama Cancer Center, Saitama, Japan.
D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000627:therapeutic use; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D006291:Health Policy; D006801:Humans; D007255:Information Services; D007564:Japan; D009369:Neoplasms / Q000150:complications*; D010146:Pain / Q000188:drug therapy*; D010166:Palliative Care
D000701:Analgesics, Opioid